Academic Journal
Q1Journal of Medical Screening
About Journal of Medical Screening
About Journal of Medical Screening
Journal of Medical Screening is a peer-reviewed scholarly journal published by SAGE Publications Ltd (United Kingdom). It focuses on Q1. Publication coverage spans 1994-2026.
Key indicators: ISSN 0969-1413, 1475-5793; H-index 72.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (72): Strong citation impact — 72 articles cited at least 72 times each, reflecting solid influence.
Publishing in Journal of Medical Screening
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Journal of Medical Screening?
0969-1413, 1475-5793.
Who publishes Journal of Medical Screening?
SAGE Publications Ltd.
What are Journal of Medical Screening's metrics?
H-index 72.
Is Journal of Medical Screening peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Global Cancer Incidence and Screening; Colorectal Cancer Screening and Detection; Cervical Cancer and HPV Research; Breast Lesions and Carcinomas; Digital Radiography and Breast Imaging; Prenatal Screening and Diagnostics.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,150.00 USD; 3,043.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Factors associated with cytology triage attendance after a hrHPV-positive self-sample and age-related differences: The lifelines cohort
Ekram S. Jemal, Albert G. Siebers, Ed Schuuring, G. Bea A. Wisman et al.
2026-10-16 · DOI: 10.1177/09691413261498648The association between the impact of cancer screening on early-stage cancers and on cancer mortality: A systematic review and meta-analysis
Julia Geppert, Nefeli Kouppa, Chris Stinton, Karoline Freeman et al.
2026-10-15 · DOI: 10.1177/09691413261498649Breast cancer overdiagnosis due to mammography screening—A long-term follow-up population study of BreastScreen Norway
Torunn Heggland, Lars J Vatten, Signe Opdahl, Harald Weedon-Fekjær et al.
2026-10-15 · DOI: 10.1177/09691413261494999Disparities in participation in the Finnish cervical cancer screening programme: The role of birth country, education level and age
Riia-Mari Seppänen, Maarit Lamminmäki, Veli-Matti Partanen
2026-10-10 · DOI: 10.1177/09691413261495461Mammogram utilization among women with vision and/or hearing loss: Insights from the 2022 Behavioral Risk Factor Surveillance Survey
Nicole Ducray, Amanda Hinson-Enslin, Heather F. McClintock
2026-10-07 · DOI: 10.1177/09691413261494817Socioeconomic inequalities in cervical cancer screening coverage in England
Clare Gilham
2026-09-30 · DOI: 10.1177/09691413261484526Risk-based lung cancer screening with low-dose computed tomography in a Canadian province: Evaluation results of a demonstration project in Quebec, Canada
José Massougbodji, Sonia Rodrigue, Simon Martel, Hélène Lizotte et al.
2026-09-17 · DOI: 10.1177/09691413261481721Impact of screening programs on the prenatal diagnosis (detection rate) of trisomy 13 and 18 over a 30-year period
Michele Santoro, Ilaria Ponziani, Laura Perna, Alessio Coi et al.
2026-09-15 · DOI: 10.1177/09691413261486810A natural history model of oesophageal adenocarcinoma to inform power calculations for the BEST4 screening trial
Rebecca Landy, John W Correira, Rebecca C Fitzgerald, Peter D Sasieni et al.
2026-08-26 · DOI: 10.1177/09691413261478764Increasing lung cancer screening referral/order and completion rates in primary care through patient outreach and shared decision making
Melissa DiCarlo, Ayako Shimada, Randa Sifri, Melanie Johnson et al.
2026-08-20 · DOI: 10.1177/09691413261479224Workplace-based screening for oral potentially malignant disorders: A systematic review and meta-analysis
Shubhi Goel, Saurav Basu, Shubhanjali Roy, Adarsh Kumar et al.
2026-08-20 · DOI: 10.1177/09691413261477031Resilience and adaptation of cancer screening programs to external crises
Douglas M Puricelli Perin, Miriam Elfström, Iris Lansdorp-Vogelaar, Nora Pashayan et al.
2026-08-13 · DOI: 10.1177/09691413261475492Should there be informed decision-making for prostate cancer screening? An analysis of preference sensitivity
Andrew Vickers, Sigrid Carlsson
2026-08-12 · DOI: 10.1177/09691413261478762Disparities in mammography screening adherence in a universal welfare healthcare system: A population-based cohort study of 100,000 women
Hadas Kadar Sfarad, Racheli Magnezi, Barak Bar Zakai, Osnat Givon-Madhala et al.
2026-08-10 · DOI: 10.1177/09691413261476973Ecological analysis of breast screening uptake and coverage in East London
Helen A Blake, Shuping Joy Li, Christina Derksen, Loubna Bijdiguen et al.
2026-08-03 · DOI: 10.1177/09691413261473166Downstaging as a direct patient benefit in cancer screening
Paul F Pinsky, Elyse M LeeVan, Wendy S Rubinstein, Christos Patriotis et al.
2026-07-31 · DOI: 10.1177/09691413261473145A systematic review and meta-analysis of diagnostic accuracy of urine self-sampling for human papillomavirus detection in cervical cancer screening
Anita Nath, Apourv Pant, Gowthaman Thangavel, Anjana Kunnumal et al.
2026-07-24 · DOI: 10.1177/09691413261471634A cross-sectional survey of sample takers’ views on HPV self-sampling for cervical screening in Ireland
Philippa White, Salma Al-Kalbani, Sarah Fitzgibbon, Rachael Comer et al.
2026-07-08 · DOI: 10.1177/09691413261466046Cost–benefit analysis of an organized community-based multi-cancer screening program in Bangladesh
Md. Ragaul Azim, Quazi Nazmus Sakib, Md. Mahfujur Rahman, Md. Sirajul Islam et al.
2026-06-09 · DOI: 10.1177/09691413261458098Response to: Adjusting for non-compliance and contamination with a more plausible assumption
Håkan Jonsson, Lennarth Nyström, Johannes Blom
2026-09 · DOI: 10.1177/09691413261454996Reviews
Community Reviews
Version History
October 9, 2026 at 8:30 pm
September 25, 2026